Lipid-lowering drugmaker Omthera raises $40M, to submit NDA this year
A specialty pharmaceutical company in Princeton, New Jersey has raised about $40 million of a target $49 million to help fund the development of its lipid-lowering drug, Epanova, according to a Form D filing with the U.S. Securities and Exchange Commission. Omthera Pharmaceuticals has so far secured 10 investors for the financing round, which began […]